Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2012-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2014-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2014506448-A |
titleOfInvention |
Binding proteins for inhibitors of clotting factors |
abstract |
The present invention relates to the identification and use of antigen binding regions, antibodies, antigen binding antibody fragments and antibody mimetics that neutralize the anticoagulant effect of an anticoagulant in vitro and / or in vivo. The antibodies and functional fragments and antibody mimetics of the present invention may be used for therapeutic (detoxification) and / or diagnostic purposes to specifically eliminate the pharmacological effects of anticoagulants such as FXa inhibitors. Can do. The invention also provides a kit with a nucleic acid sequence encoding the molecule, a vector containing it, a pharmaceutical composition, and instructions for use. |
priorityDate |
2011-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |